Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Geoff Meacham's Stock Ratings
B of A Securities Analyst
Geoff Meacham is an analyst at B of A Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/02/2025
Overall Average Return
4.06%
Smart Score
Overall Average Return Percentile
49th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 04/02/2025 | NMRA | Buy Now | Neumora Therapeutics | $0.77 | 30.23% | Geoff Meacham63% | $7 → $1 | Downgrade | Buy → Underperform | Get Alert |
| 03/13/2025 | MRNA | Buy Now | Moderna | $27.52 | 45.35% | Geoff Meacham63% | → $40 | Initiates | → Neutral | Get Alert |
| 03/13/2025 | KYMR | Buy Now | Kymera Therapeutics | $35.71 | 45.62% | Geoff Meacham63% | → $52 | Initiates | → Buy | Get Alert |
| 03/13/2025 | KNSA | Buy Now | Kiniksa Pharmaceuticals | $27.77 | 44.07% | Geoff Meacham63% | → $40 | Initiates | → Buy | Get Alert |
| 03/13/2025 | BNTX | Buy Now | BioNTech | $104.55 | 38.7% | Geoff Meacham63% | → $145 | Initiates | → Buy | Get Alert |
| 03/13/2025 | RNA | Buy Now | Avidity Biosciences | $33.04 | 111.86% | Geoff Meacham63% | → $70 | Initiates | → Buy | Get Alert |
| 03/13/2025 | APGE | Buy Now | Apogee Therapeutics | $40.00 | 137.5% | Geoff Meacham63% | → $95 | Initiates | → Buy | Get Alert |
| 03/13/2025 | ETNB | Buy Now | 89bio | $8.70 | 187.36% | Geoff Meacham63% | → $25 | Initiates | → Buy | Get Alert |
| 03/10/2025 | RNA | Buy Now | Avidity Biosciences | $33.04 | 45.28% | Geoff Meacham63% | $51 → $48 | Maintains | Buy | Get Alert |
| 02/20/2025 | BMRN | Buy Now | Biomarin Pharmaceutical | $62.61 | 64.51% | Geoff Meacham63% | $99 → $103 | Maintains | Buy | Get Alert |
| 02/13/2025 | BIIB | Buy Now | Biogen | $121.97 | 18.89% | Geoff Meacham63% | $160 → $145 | Maintains | Neutral | Get Alert |
| 02/03/2025 | ABBV | Buy Now | AbbVie | $195.53 | 9.96% | Geoff Meacham63% | $205 → $215 | Maintains | Buy | Get Alert |
| 01/28/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $606.35 | 23.69% | Geoff Meacham63% | $795 → $750 | Maintains | Neutral | Get Alert |
| 01/28/2025 | BIIB | Buy Now | Biogen | $121.97 | 31.19% | Geoff Meacham63% | $190 → $160 | Maintains | Neutral | Get Alert |
| 01/28/2025 | AMGN | Buy Now | Amgen | $277.38 | 6.35% | Geoff Meacham63% | $310 → $295 | Maintains | Neutral | Get Alert |
| 01/28/2025 | ABBV | Buy Now | AbbVie | $195.53 | 4.84% | Geoff Meacham63% | $215 → $205 | Maintains | Buy | Get Alert |
| 01/14/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $606.35 | 31.11% | Geoff Meacham63% | $895 → $795 | Maintains | Neutral | Get Alert |
| 01/07/2025 | CRSP | Buy Now | CRISPR Therapeutics | $38.63 | 120.04% | Geoff Meacham63% | $98 → $85 | Maintains | Buy | Get Alert |
| 01/07/2025 | BTAI | Buy Now | BioXcel Therapeutics | $1.80 | -86.11% | Geoff Meacham63% | $112 → $4 | Downgrade | Buy → Underperform | Get Alert |
| 01/06/2025 | NMRA | Buy Now | Neumora Therapeutics | $0.77 | 811.64% | Geoff Meacham63% | $22 → $7 | Maintains | Buy | Get Alert |
| 11/25/2024 | BBIO | Buy Now | BridgeBio Pharma | $38.23 | 17.72% | Geoff Meacham63% | $42 → $45 | Maintains | Buy | Get Alert |
| 11/14/2024 | GILD | Buy Now | Gilead Sciences | $103.45 | 20.83% | Geoff Meacham63% | → $125 | Initiates | → Buy | Get Alert |
| 11/14/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $606.35 | 47.61% | Geoff Meacham63% | → $895 | Initiates | → Neutral | Get Alert |
| 11/14/2024 | BIIB | Buy Now | Biogen | $121.97 | 55.78% | Geoff Meacham63% | → $190 | Initiates | → Neutral | Get Alert |
| 11/14/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.38 | 14.68% | Geoff Meacham63% | → $575 | Initiates | → Buy | Get Alert |
| 11/14/2024 | AMGN | Buy Now | Amgen | $277.38 | 20.77% | Geoff Meacham63% | → $335 | Initiates | → Neutral | Get Alert |
| 11/12/2024 | ABBV | Buy Now | AbbVie | $195.53 | 9.96% | Geoff Meacham63% | $226 → $215 | Maintains | Buy | Get Alert |
| 10/31/2024 | ABBV | Buy Now | AbbVie | $195.53 | 15.58% | Geoff Meacham63% | $215 → $226 | Maintains | Buy | Get Alert |
| 10/31/2024 | LLY | Buy Now | Eli Lilly | $816.25 | 34.76% | Geoff Meacham63% | $1150 → $1100 | Maintains | Buy | Get Alert |
| 10/30/2024 | LYEL | Buy Now | Lyell Immunopharma | $0.47 | 112.77% | Geoff Meacham63% | $6 → $1 | Downgrade | Buy → Underperform | Get Alert |
| 10/18/2024 | ABBV | Buy Now | AbbVie | $195.53 | -0.27% | Geoff Meacham63% | $185 → $195 | Maintains | Neutral | Get Alert |
| 10/18/2024 | TYRA | Buy Now | Tyra Biosciences | $10.60 | 192.45% | Geoff Meacham63% | $22 → $31 | Upgrade | Neutral → Buy | Get Alert |
| 09/17/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $62.61 | 83.68% | Geoff Meacham63% | $130 → $115 | Maintains | Buy | Get Alert |
| 09/13/2024 | MRNA | Buy Now | Moderna | $27.52 | 299.71% | Geoff Meacham63% | $130 → $110 | Maintains | Neutral | Get Alert |
| 09/11/2024 | BBIO | Buy Now | BridgeBio Pharma | $38.23 | 9.88% | Geoff Meacham63% | $42 → $42 | Maintains | Buy | Get Alert |
| 08/19/2024 | TSBX | Buy Now | Turnstone Biologics | $0.34 | 2845.07% | Geoff Meacham63% | $12 → $10 | Maintains | Buy | Get Alert |
| 08/09/2024 | LLY | Buy Now | Eli Lilly | $816.25 | 37.82% | Geoff Meacham63% | $1000 → $1125 | Maintains | Buy | Get Alert |
| 08/07/2024 | AMGN | Buy Now | Amgen | $277.38 | 18.97% | Geoff Meacham63% | $325 → $330 | Maintains | Neutral | Get Alert |
| 07/31/2024 | MRK | Buy Now | Merck & Co | $83.82 | 72.99% | Geoff Meacham63% | $150 → $145 | Maintains | Buy | Get Alert |
| 06/27/2024 | LYEL | Buy Now | Lyell Immunopharma | $0.47 | 1176.6% | Geoff Meacham63% | $9 → $6 | Maintains | Buy | Get Alert |
| 06/25/2024 | BBIO | Buy Now | BridgeBio Pharma | $38.23 | 9.88% | Geoff Meacham63% | $50 → $42 | Maintains | Buy | Get Alert |
| 06/24/2024 | LLY | Buy Now | Eli Lilly and Co | $816.25 | 22.51% | Geoff Meacham63% | $1000 → $1000 | Maintains | Buy | Get Alert |
| 06/13/2024 | RNA | Buy Now | Avidity Biosciences | $33.04 | 36.2% | Geoff Meacham63% | $40 → $45 | Maintains | Buy | Get Alert |
| 05/10/2024 | APGE | Buy Now | Apogee Therapeutics | $40.00 | 100% | Geoff Meacham63% | → $80 | Initiates | → Buy | Get Alert |
| 05/03/2024 | RNA | Buy Now | Avidity Biosciences | $33.04 | 21.07% | Geoff Meacham63% | → $40 | Initiates | → Buy | Get Alert |
| 04/17/2024 | JNJ | Buy Now | Johnson & Johnson | $155.95 | 9.01% | Geoff Meacham63% | $180 → $170 | Maintains | Neutral | Get Alert |
| 04/12/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $606.35 | 18.74% | Geoff Meacham63% | $710 → $720 | Maintains | Underperform | Get Alert |
| 04/12/2024 | RPRX | Buy Now | Royalty Pharma | $32.52 | 16.85% | Geoff Meacham63% | $40 → $38 | Maintains | Buy | Get Alert |
| 04/12/2024 | BIIB | Buy Now | Biogen | $121.97 | 113.18% | Geoff Meacham63% | $280 → $260 | Maintains | Neutral | Get Alert |
| 03/13/2024 | BTAI | Buy Now | BioXcel Therapeutics | $1.80 | 288.89% | Geoff Meacham63% | $128 → $112 | Maintains | Buy | Get Alert |
| 03/13/2024 | JANX | Buy Now | Janux Therapeutics | $32.38 | 48.24% | Geoff Meacham63% | $24 → $48 | Maintains | Buy | Get Alert |
| 03/01/2024 | LLY | Buy Now | Eli Lilly and Co | $816.25 | 22.51% | Geoff Meacham63% | $800 → $1000 | Maintains | Buy | Get Alert |
| 01/03/2024 | KYMR | Buy Now | Kymera Therapeutics | $35.71 | -15.99% | Geoff Meacham63% | $45 → $30 | Downgrade | Buy → Neutral | Get Alert |
| 01/03/2024 | LIAN | Buy Now | LianBio | — | — | Geoff Meacham63% | $5 → $3 | Downgrade | Buy → Underperform | Get Alert |
| 01/03/2024 | BMY | Buy Now | Bristol-Myers Squibb | $49.89 | 20.26% | Geoff Meacham63% | $68 → $60 | Downgrade | Buy → Neutral | Get Alert |
| 12/27/2023 | BMY | Buy Now | Bristol-Myers Squibb | $49.89 | 36.3% | Geoff Meacham63% | $72 → $68 | Maintains | Buy | Get Alert |
| 12/15/2023 | IGMS | Buy Now | IGM Biosciences | $1.36 | 488.24% | Geoff Meacham63% | → $8 | Downgrade | Buy → Neutral | Get Alert |
| 10/11/2023 | AMGN | Buy Now | Amgen | $277.38 | 4.55% | Geoff Meacham63% | → $290 | Reinstates | → Neutral | Get Alert |
| 10/10/2023 | NMRA | Buy Now | Neumora Therapeutics | $0.77 | 2244.21% | Geoff Meacham63% | → $18 | Initiates | → Buy | Get Alert |
| 09/08/2023 | VIR | Buy Now | Vir Biotechnology | $6.17 | 126.9% | Geoff Meacham63% | $23 → $14 | Downgrade | Buy → Neutral | Get Alert |
| 09/08/2023 | GILD | Buy Now | Gilead Sciences | $103.45 | -8.17% | Geoff Meacham63% | $88 → $95 | Upgrade | Neutral → Buy | Get Alert |
| 08/21/2023 | CVAC | Buy Now | CureVac | $3.71 | 115.92% | Geoff Meacham63% | $10 → $8 | Maintains | Underperform | Get Alert |
| 08/21/2023 | RANI | Buy Now | Rani Therapeutics Hldgs | $1.08 | 1474.07% | Geoff Meacham63% | $19 → $17 | Maintains | Buy | Get Alert |
| 08/15/2023 | TSBX | Buy Now | Turnstone Biologics | $0.34 | 5201.13% | Geoff Meacham63% | → $18 | Initiates | → Buy | Get Alert |
| 08/04/2023 | MRNA | Buy Now | Moderna | $27.52 | 445.06% | Geoff Meacham63% | $175 → $150 | Maintains | Neutral | Get Alert |
| 07/28/2023 | BMY | Buy Now | Bristol-Myers Squibb | $49.89 | 60.35% | Geoff Meacham63% | $85 → $80 | Maintains | Buy | Get Alert |
| 07/21/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $62.61 | 195.48% | Geoff Meacham63% | $200 → $185 | Maintains | Buy | Get Alert |
| 07/20/2023 | ABOS | Buy Now | Acumen Pharmaceuticals | $1.05 | 1233.21% | Geoff Meacham63% | → $14 | Reinstates | → Buy | Get Alert |
| 05/23/2023 | ICPT | Buy Now | Intercept Pharma | — | — | Geoff Meacham63% | $17 → $14 | Maintains | Underperform | Get Alert |
| 05/04/2023 | BIIB | Buy Now | Biogen | $121.97 | 162.37% | Geoff Meacham63% | $300 → $320 | Maintains | Neutral | Get Alert |
| 04/21/2023 | PFE | Buy Now | Pfizer | $24.10 | 86.72% | Geoff Meacham63% | $50 → $45 | Maintains | Neutral | Get Alert |
| 04/21/2023 | BMY | Buy Now | Bristol-Myers Squibb | $49.89 | 70.37% | Geoff Meacham63% | $82 → $85 | Maintains | Buy | Get Alert |
| 04/21/2023 | BIIB | Buy Now | Biogen | $121.97 | 145.97% | Geoff Meacham63% | $295 → $300 | Maintains | Neutral | Get Alert |
| 02/23/2023 | GRPH | Buy Now | Graphite Bio | — | — | Geoff Meacham63% | $21 → $14 | Downgrade | Neutral → Underperform | Get Alert |
| 01/18/2023 | GRPH | Buy Now | Graphite Bio | — | — | Geoff Meacham63% | $49 → $21 | Downgrade | Buy → Neutral | Get Alert |
| 01/05/2023 | AMLX | Buy Now | Amylyx Pharma | $5.14 | 872.76% | Geoff Meacham63% | → $50 | Initiates | → Buy | Get Alert |
| 01/04/2023 | MRK | Buy Now | Merck & Co | $83.82 | 55.09% | Geoff Meacham63% | $110 → $130 | Upgrade | Neutral → Buy | Get Alert |
| 01/04/2023 | PFE | Buy Now | Pfizer | $24.10 | 148.96% | Geoff Meacham63% | → $60 | Downgrade | Buy → Neutral | Get Alert |
| 12/14/2022 | ABBV | Buy Now | AbbVie | $195.53 | -15.61% | Geoff Meacham63% | $162 → $165 | Maintains | Neutral | Get Alert |
| 12/13/2022 | GILD | Buy Now | Gilead Sciences | $103.45 | -17.84% | Geoff Meacham63% | → $85 | Reinstates | → Neutral | Get Alert |
| 12/05/2022 | ABBV | Buy Now | AbbVie | $195.53 | -17.15% | Geoff Meacham63% | $160 → $162 | Maintains | Neutral | Get Alert |
| 11/01/2022 | INO | Buy Now | Inovio Pharmaceuticals | $1.92 | 4.44% | Geoff Meacham63% | → $24 | Downgrade | Neutral → Underperform | Get Alert |
| 10/03/2022 | ICPT | Buy Now | Intercept Pharma | — | — | Geoff Meacham63% | $16 → $14 | Maintains | Underperform | Get Alert |
| 08/29/2022 | IGMS | Buy Now | IGM Biosciences | $1.36 | 2400% | Geoff Meacham63% | → $34 | Initiates | → Buy | Get Alert |
| 07/07/2022 | LLY | Buy Now | Eli Lilly | $816.25 | -56.51% | Geoff Meacham63% | $333 → $355 | Maintains | Overweight | Get Alert |
| 06/21/2022 | ABBV | Buy Now | AbbVie | $195.53 | -20.22% | Geoff Meacham63% | → $156 | Reiterates | → Neutral | Get Alert |
| 06/08/2022 | OMER | Buy Now | Omeros | $7.04 | -43.18% | Geoff Meacham63% | $12 → $4 | Downgrade | Buy → Neutral | Get Alert |
| 04/22/2022 | ABBV | Buy Now | AbbVie | $195.53 | -20.22% | Geoff Meacham63% | $152 → $156 | Maintains | Neutral | Get Alert |
| 03/28/2022 | BIIB | Buy Now | Biogen | $121.97 | 84.48% | Geoff Meacham63% | $230 → $225 | Maintains | Neutral | Get Alert |
| 03/17/2022 | ABBV | Buy Now | AbbVie | $195.53 | -22.26% | Geoff Meacham63% | $145 → $152 | Maintains | Neutral | Get Alert |
| 02/03/2022 | ABBV | Buy Now | AbbVie | $195.53 | -29.42% | Geoff Meacham63% | $135 → $138 | Maintains | Neutral | Get Alert |
| 01/21/2022 | CVAC | Buy Now | CureVac | $3.71 | 439.81% | Geoff Meacham63% | $55 → $20 | Downgrade | Neutral → Underperform | Get Alert |
| 01/21/2022 | ABOS | Buy Now | Acumen Pharmaceuticals | $1.05 | 1233.21% | Geoff Meacham63% | $16 → $14 | Upgrade | Neutral → Buy | Get Alert |
| 01/21/2022 | INO | Buy Now | Inovio Pharmaceuticals | $1.92 | 422.19% | Geoff Meacham63% | $96 → $120 | Upgrade | Underperform → Neutral | Get Alert |
| 01/21/2022 | MRNA | Buy Now | Moderna | $27.52 | 554.07% | Geoff Meacham63% | $135 → $180 | Upgrade | Underperform → Neutral | Get Alert |
| 01/05/2022 | AMGN | Buy Now | Amgen | $277.38 | -8.07% | Geoff Meacham63% | $285 → $255 | Downgrade | Buy → Neutral | Get Alert |
| 01/05/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $606.35 | -5.17% | Geoff Meacham63% | $675 → $575 | Downgrade | Neutral → Underperform | Get Alert |
| 01/05/2022 | PFE | Buy Now | Pfizer | $24.10 | 190.46% | Geoff Meacham63% | $59 → $70 | Upgrade | Neutral → Buy | Get Alert |
| 12/29/2021 | KNSA | Buy Now | Kiniksa Pharmaceuticals | $27.77 | 22.46% | Geoff Meacham63% | $37 → $34 | Maintains | Buy | Get Alert |
| 12/23/2021 | BIIB | Buy Now | Biogen | $121.97 | 125.47% | Geoff Meacham63% | $295 → $275 | Maintains | Neutral | Get Alert |
| 12/06/2021 | VAXX | Buy Now | Vaxxinity | $0.04 | 46566.67% | Geoff Meacham63% | → $21 | Initiates | → Buy | Get Alert |
| 10/11/2021 | TYRA | Buy Now | Tyra Biosciences | $10.60 | 107.55% | Geoff Meacham63% | → $22 | Initiates | → Buy | Get Alert |
| 10/06/2021 | CMPI | Buy Now | Checkmate Pharmaceuticals | — | — | Geoff Meacham63% | → $7 | Upgrade | Neutral → Buy | Get Alert |
| 09/10/2021 | INO | Buy Now | Inovio Pharmaceuticals | $1.92 | 317.75% | Geoff Meacham63% | $108 → $96 | Downgrade | Neutral → Underperform | Get Alert |
| 09/10/2021 | BBIO | Buy Now | BridgeBio Pharma | $38.23 | 96.21% | Geoff Meacham63% | → $75 | Upgrade | Neutral → Buy | Get Alert |
| 09/10/2021 | KYMR | Buy Now | Kymera Therapeutics | $35.71 | 124.03% | Geoff Meacham63% | $65 → $80 | Upgrade | Neutral → Buy | Get Alert |
| 08/10/2021 | ERAS | Buy Now | Erasca | $1.51 | 1754.3% | Geoff Meacham63% | → $28 | Initiates | → Buy | Get Alert |
| 08/02/2021 | ABBV | Buy Now | AbbVie | $195.53 | -39.14% | Geoff Meacham63% | $115 → $119 | Maintains | Neutral | Get Alert |
| 07/26/2021 | ABOS | Buy Now | Acumen Pharmaceuticals | $1.05 | 1804.58% | Geoff Meacham63% | → $20 | Initiates | → Neutral | Get Alert |
| 07/20/2021 | GRPH | Buy Now | Graphite Bio | — | — | Geoff Meacham63% | → $245 | Initiates | → Buy | Get Alert |
| 07/13/2021 | IPSC | Buy Now | Century Therapeutics | $0.56 | 5994.28% | Geoff Meacham63% | → $34 | Initiates | → Buy | Get Alert |
| 07/12/2021 | LYEL | Buy Now | Lyell Immunopharma | $0.47 | 5219.15% | Geoff Meacham63% | → $25 | Initiates | → Buy | Get Alert |
| 07/06/2021 | JANX | Buy Now | Janux Therapeutics | $32.38 | 8.09% | Geoff Meacham63% | → $35 | Initiates | → Buy | Get Alert |
| 06/17/2021 | CVAC | Buy Now | CureVac | $3.71 | 1249.53% | Geoff Meacham63% | → $50 | Downgrade | Buy → Neutral | Get Alert |
| 05/19/2021 | ABBV | Buy Now | AbbVie | $195.53 | -42.21% | Geoff Meacham63% | $110 → $113 | Maintains | Neutral | Get Alert |
| 05/07/2021 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.32 | 1196.3% | Geoff Meacham63% | $56 → $56 | Upgrade | Neutral → Buy | Get Alert |
| 03/23/2021 | INO | Buy Now | Inovio Pharmaceuticals | $1.92 | 578.85% | Geoff Meacham63% | → $156 | Initiates | → Neutral | Get Alert |
| 02/01/2021 | MRNA | Buy Now | Moderna | $27.52 | — | Geoff Meacham63% | — | Downgrade | Neutral → Underperform | Get Alert |
| 01/22/2021 | MRNA | Buy Now | Moderna | $27.52 | 408.72% | Geoff Meacham63% | $130 → $140 | Maintains | Neutral | Get Alert |
| 01/15/2021 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.32 | 1196.3% | Geoff Meacham63% | → $56 | Downgrade | Buy → Neutral | Get Alert |
| 01/15/2021 | ICPT | Buy Now | Intercept Pharma | — | — | Geoff Meacham63% | — | Downgrade | Neutral → Underperform | Get Alert |
| 01/15/2021 | ESPR | Buy Now | Esperion Therapeutics | $1.01 | 3368.44% | Geoff Meacham63% | → $35 | Downgrade | Buy → Neutral | Get Alert |
| 01/15/2021 | SGEN | Buy Now | Seagen | — | — | Geoff Meacham63% | — | Upgrade | Neutral → Buy | Get Alert |
| 01/05/2021 | ICPT | Buy Now | Intercept Pharma | — | — | Geoff Meacham63% | $55 → $40 | Maintains | Neutral | Get Alert |
| 12/11/2020 | ABBV | Buy Now | AbbVie | $195.53 | -43.74% | Geoff Meacham63% | $97 → $110 | Maintains | Neutral | Get Alert |
| 11/23/2020 | GLTO | Buy Now | Galecto | $3.03 | 593.07% | Geoff Meacham63% | → $525 | Initiates | → Buy | Get Alert |
| 11/09/2020 | BIIB | Buy Now | Biogen | $121.97 | 96.78% | Geoff Meacham63% | → $240 | Downgrade | Neutral → Underperform | Get Alert |
| 11/05/2020 | BIIB | Buy Now | Biogen | $121.97 | 195.17% | Geoff Meacham63% | $230 → $360 | Upgrade | Underperform → Neutral | Get Alert |
| 10/29/2020 | AMGN | Buy Now | Amgen | $277.38 | -4.46% | Geoff Meacham63% | $275 → $265 | Maintains | Buy | Get Alert |
| 10/20/2020 | PMVP | Buy Now | PMV Pharma | $1.01 | 4058.42% | Geoff Meacham63% | → $42 | Initiates | → Buy | Get Alert |
| 10/20/2020 | OMER | Buy Now | Omeros | $7.04 | 198.3% | Geoff Meacham63% | → $21 | Initiates | → Buy | Get Alert |
| 10/15/2020 | SGEN | Buy Now | Seagen | — | — | Geoff Meacham63% | $180 → $215 | Maintains | Neutral | Get Alert |
| 10/15/2020 | ESPR | Buy Now | Esperion Therapeutics | $1.01 | 5053.11% | Geoff Meacham63% | $55 → $52 | Maintains | Buy | Get Alert |
| 10/15/2020 | BIIB | Buy Now | Biogen | $121.97 | 92.68% | Geoff Meacham63% | $255 → $235 | Maintains | Underperform | Get Alert |
| 10/07/2020 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.32 | 964.81% | Geoff Meacham63% | $48 → $46 | Upgrade | Neutral → Buy | Get Alert |
| 10/05/2020 | VIR | Buy Now | Vir Biotechnology | $6.17 | 791.41% | Geoff Meacham63% | → $55 | Initiates | → Buy | Get Alert |
| 10/05/2020 | CRSP | Buy Now | CRISPR Therapeutics | $38.63 | 184.75% | Geoff Meacham63% | → $110 | Initiates | → Buy | Get Alert |
| 09/15/2020 | MGTX | Buy Now | MeiraGTx Hldgs | $7.49 | 167.02% | Geoff Meacham63% | → $20 | Reinstates | → Buy | Get Alert |
| 09/15/2020 | KYMR | Buy Now | Kymera Therapeutics | $35.71 | -1.99% | Geoff Meacham63% | → $35 | Initiates | → Neutral | Get Alert |
| 09/08/2020 | CVAC | Buy Now | CureVac | $3.71 | 1789.34% | Geoff Meacham63% | → $70 | Initiates | → Buy | Get Alert |
| 09/08/2020 | SGMO | Buy Now | Sangamo Therapeutics | $0.74 | 2607.09% | Geoff Meacham63% | → $20 | Reinstates | → Buy | Get Alert |
| 09/01/2020 | CMPI | Buy Now | Checkmate Pharmaceuticals | — | — | Geoff Meacham63% | → $19 | Initiates | → Neutral | Get Alert |
| 08/17/2020 | ESPR | Buy Now | Esperion Therapeutics | $1.01 | 5350.4% | Geoff Meacham63% | $60 → $55 | Maintains | Buy | Get Alert |
| 08/04/2020 | PSTX | Buy Now | Poseida Therapeutics | — | — | Geoff Meacham63% | → $20 | Initiates | → Buy | Get Alert |
| 07/13/2020 | RPRX | Buy Now | Royalty Pharma | $32.52 | 69.13% | Geoff Meacham63% | → $55 | Initiates | → Buy | Get Alert |
| 07/13/2020 | BTAI | Buy Now | BioXcel Therapeutics | $1.80 | 3400% | Geoff Meacham63% | $848 → $1008 | Reiterates | → Buy | Get Alert |
| 06/25/2020 | PBYI | Buy Now | Puma Biotechnology | $3.13 | 188% | Geoff Meacham63% | → $9 | Reinstates | → Underperform | Get Alert |
| 06/25/2020 | BBIO | Buy Now | BridgeBio Pharma | $38.23 | -0.59% | Geoff Meacham63% | → $38 | Initiates | → Neutral | Get Alert |
| 06/25/2020 | RGNX | Buy Now | Regenxbio | $10.15 | 490.84% | Geoff Meacham63% | → $60 | Reinstates | → Buy | Get Alert |
| 06/25/2020 | GNFT | Buy Now | Genfit | $4.35 | 60.92% | Geoff Meacham63% | → $7 | Initiates | → Underperform | Get Alert |
| 05/19/2020 | MRNA | Buy Now | Moderna | $27.52 | 245.2% | Geoff Meacham63% | $70 → $95 | Maintains | Neutral | Get Alert |
| 05/01/2020 | AMGN | Buy Now | Amgen | $277.38 | -4.46% | Geoff Meacham63% | $250 → $265 | Reiterates | → Buy | Get Alert |
| 04/01/2020 | KNSA | Buy Now | Kiniksa Pharmaceuticals | $27.77 | -9.96% | Geoff Meacham63% | → $25 | Initiates | → Buy | Get Alert |
| 04/01/2020 | ESPR | Buy Now | Esperion Therapeutics | $1.01 | 4854.91% | Geoff Meacham63% | → $50 | Initiates | → Buy | Get Alert |
| 04/01/2020 | EIDX | Buy Now | Eidos Therapeutics | — | — | Geoff Meacham63% | → $51 | Initiates | → Neutral | Get Alert |
| 04/01/2020 | BTAI | Buy Now | BioXcel Therapeutics | $1.80 | 2400% | Geoff Meacham63% | → $720 | Initiates | → Buy | Get Alert |
| 03/23/2020 | IIVI | Buy Now | II-VI | — | — | Geoff Meacham63% | → $31 | Initiates | → Overweight | Get Alert |
| 03/05/2020 | MRNA | Buy Now | Moderna | $27.52 | — | Geoff Meacham63% | — | Downgrade | Buy → Neutral | Get Alert |
| 03/05/2020 | AMGN | Buy Now | Amgen | $277.38 | -9.87% | Geoff Meacham63% | $245 → $250 | Upgrade | Neutral → Buy | Get Alert |
| 03/05/2020 | ICPT | Buy Now | Intercept Pharma | — | — | Geoff Meacham63% | → $111 | Initiates | → Neutral | Get Alert |
| 03/05/2020 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Geoff Meacham63% | $130 → $110 | Downgrade | Buy → Neutral | Get Alert |
| 02/25/2020 | RTRX | Buy Now | Retrophin | — | — | Geoff Meacham63% | → $19 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/18/2020 | SGEN | Buy Now | Seagen | — | — | Geoff Meacham63% | → $124 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/03/2019 | MRNA | Buy Now | Moderna | $27.52 | 5.38% | Geoff Meacham63% | → $29 | Reinstates | → Buy | Get Alert |
| 10/17/2019 | AMGN | Buy Now | Amgen | $277.38 | -22.49% | Geoff Meacham63% | → $215 | Reinstates | → Neutral | Get Alert |
| 10/17/2019 | REGN | Buy Now | Regeneron Pharmaceuticals | $606.35 | -46.4% | Geoff Meacham63% | → $325 | Reinstates | → Neutral | Get Alert |
| 08/23/2019 | RTRX | Buy Now | Retrophin | — | — | Geoff Meacham63% | $36 → $20 | Maintains | Overweight | Get Alert |
| 08/05/2019 | ZYME | Buy Now | Zymeworks | $13.14 | 75.04% | Geoff Meacham63% | $15 → $23 | Maintains | Equal-Weight | Get Alert |
| 05/09/2019 | BIIB | Buy Now | Biogen | $121.97 | 100.88% | Geoff Meacham63% | $250 → $245 | Maintains | Equal-Weight | Get Alert |
| 05/03/2019 | INCY | Buy Now | Incyte | $61.80 | 32.68% | Geoff Meacham63% | $90 → $82 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 05/03/2019 | CELG | Buy Now | Celgene | — | — | Geoff Meacham63% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 05/03/2019 | BMY | Buy Now | Bristol-Myers Squibb | $49.89 | 10.24% | Geoff Meacham63% | $53 → $55 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 04/22/2019 | RTRX | Buy Now | Retrophin | — | — | Geoff Meacham63% | → $36 | Initiates | → Overweight | Get Alert |
| 03/01/2019 | UTHR | Buy Now | United Therapeutics | $295.94 | -67.9% | Geoff Meacham63% | $100 → $95 | Maintains | Underweight | Get Alert |
| 02/13/2019 | MYOV | Buy Now | Myovant Sciences | — | — | Geoff Meacham63% | $22 → $25 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 01/02/2019 | MRNA | Buy Now | Moderna | $27.52 | -27.33% | Geoff Meacham63% | → $20 | Initiates | → Buy | Get Alert |
| 12/20/2018 | DBVT | Buy Now | DBV Technologies | $8.68 | -7.83% | Geoff Meacham63% | $300 → $80 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/06/2018 | PTCT | Buy Now | PTC Therapeutics | $49.60 | -19.36% | Geoff Meacham63% | $43 → $40 | Maintains | Equal-Weight | Get Alert |
| 10/26/2018 | SGEN | Buy Now | Seagen | — | — | Geoff Meacham63% | $95 → $90 | Maintains | Overweight | Get Alert |
| 10/23/2018 | GRTS | Buy Now | Gritstone Bio | — | — | Geoff Meacham63% | → $25 | Initiates | → Overweight | Get Alert |
| 10/12/2018 | MRK | Buy Now | Merck & Co | $83.82 | -6.94% | Geoff Meacham63% | $75 → $78 | Maintains | Overweight | Get Alert |
| 10/12/2018 | LLY | Buy Now | Eli Lilly | $816.25 | -85.3% | Geoff Meacham63% | $112 → $120 | Maintains | Overweight | Get Alert |
| 10/12/2018 | BMY | Buy Now | Bristol-Myers Squibb | $49.89 | 16.26% | Geoff Meacham63% | $55 → $58 | Maintains | Equal-Weight | Get Alert |
| 10/03/2018 | SGEN | Buy Now | Seagen | — | — | Geoff Meacham63% | $80 → $95 | Maintains | Overweight | Get Alert |
| 09/18/2018 | LLY | Buy Now | Eli Lilly | $816.25 | -86.28% | Geoff Meacham63% | $107 → $112 | Maintains | Overweight | Get Alert |
| 09/07/2018 | MRK | Buy Now | Merck & Co | $83.82 | -10.52% | Geoff Meacham63% | $70 → $75 | Maintains | Overweight | Get Alert |
| 09/07/2018 | LLY | Buy Now | Eli Lilly | $816.25 | -86.89% | Geoff Meacham63% | $98 → $107 | Maintains | Overweight | Get Alert |
| 08/23/2018 | PFE | Buy Now | Pfizer | $24.10 | 65.98% | Geoff Meacham63% | $38 → $40 | Maintains | Equal-Weight | Get Alert |
| 08/08/2018 | PTCT | Buy Now | PTC Therapeutics | $49.60 | -13.32% | Geoff Meacham63% | $40 → $43 | Maintains | Equal-Weight | Get Alert |
| 08/06/2018 | REGN | Buy Now | Regeneron Pharmaceuticals | $606.35 | -49.7% | Geoff Meacham63% | $290 → $305 | Maintains | Underweight | Get Alert |
| 08/01/2018 | NBIX | Buy Now | Neurocrine Biosciences | $108.61 | 24.29% | Geoff Meacham63% | $100 → $135 | Maintains | Overweight | Get Alert |
| 07/25/2018 | BIIB | Buy Now | Biogen | $121.97 | 162.37% | Geoff Meacham63% | $295 → $320 | Maintains | Equal-Weight | Get Alert |
| 06/20/2018 | SGMO | Buy Now | Sangamo Therapeutics | $0.74 | 3148.51% | Geoff Meacham63% | → $24 | Initiates | → Buy | Get Alert |
| 06/20/2018 | PTCT | Buy Now | PTC Therapeutics | $49.60 | — | Geoff Meacham63% | — | Upgrade | Underweight → Equal-Weight | Get Alert |
| 05/21/2018 | PRTA | Buy Now | Prothena Corp | $9.03 | — | Geoff Meacham63% | — | Downgrade | Equal-Weight → Underweight | Get Alert |
| 05/11/2018 | ZYME | Buy Now | Zymeworks | $13.14 | — | Geoff Meacham63% | — | Upgrade | Underweight → Equal-Weight | Get Alert |
| 05/03/2018 | UTHR | Buy Now | United Therapeutics | $295.94 | -67.9% | Geoff Meacham63% | $105 → $95 | Maintains | Underweight | Get Alert |
| 05/03/2018 | IRWD | Buy Now | Ironwood Pharmaceuticals | $0.93 | 2049.61% | Geoff Meacham63% | $16 → $20 | Maintains | Equal-Weight | Get Alert |
| 05/02/2018 | GILD | Buy Now | Gilead Sciences | $103.45 | -13.01% | Geoff Meacham63% | $95 → $90 | Maintains | Overweight | Get Alert |
| 04/27/2018 | BMY | Buy Now | Bristol-Myers Squibb | $49.89 | 10.24% | Geoff Meacham63% | $65 → $55 | Maintains | Equal-Weight | Get Alert |
| 04/05/2018 | PRTA | Buy Now | Prothena Corp | $9.03 | 453.71% | Geoff Meacham63% | $70 → $50 | Maintains | Overweight | Get Alert |
| 04/05/2018 | INCY | Buy Now | Incyte | $61.80 | 118.43% | Geoff Meacham63% | $165 → $135 | Maintains | Overweight | Get Alert |
| 04/05/2018 | AMGN | Buy Now | Amgen | $277.38 | -35.11% | Geoff Meacham63% | $190 → $180 | Maintains | Equal-Weight | Get Alert |
| 04/05/2018 | ABBV | Buy Now | AbbVie | $195.53 | -47.83% | Geoff Meacham63% | $120 → $102 | Maintains | Equal-Weight | Get Alert |
| 04/05/2018 | BIIB | Buy Now | Biogen | $121.97 | — | Geoff Meacham63% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/05/2018 | MYOV | Buy Now | Myovant Sciences | — | — | Geoff Meacham63% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/05/2018 | MRK | Buy Now | Merck & Co | $83.82 | — | Geoff Meacham63% | — | Upgrade | Equal-Weight → Overweight | Get Alert |
| 04/05/2018 | PFE | Buy Now | Pfizer | $24.10 | — | Geoff Meacham63% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/05/2018 | BHVN | Buy Now | Biohaven | $23.26 | — | Geoff Meacham63% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/04/2018 | PTCT | Buy Now | PTC Therapeutics | $49.60 | — | Geoff Meacham63% | — | Downgrade | Equal-Weight → Underweight | Get Alert |
| 04/02/2018 | BTAI | Buy Now | BioXcel Therapeutics | $1.80 | 733.33% | Geoff Meacham63% | → $240 | Initiates | → Overweight | Get Alert |
| 03/07/2018 | PTCT | Buy Now | PTC Therapeutics | $49.60 | -51.62% | Geoff Meacham63% | $18 → $24 | Maintains | Equal-Weight | Get Alert |
| 03/06/2018 | GILD | Buy Now | Gilead Sciences | $103.45 | -8.17% | Geoff Meacham63% | $90 → $95 | Maintains | Overweight | Get Alert |
| 02/28/2018 | XLRN | Buy Now | Acceleron Pharma | — | — | Geoff Meacham63% | $50 → $54 | Maintains | Overweight | Get Alert |
| 02/22/2018 | UTHR | Buy Now | United Therapeutics | $295.94 | -64.52% | Geoff Meacham63% | $115 → $105 | Maintains | Underweight | Get Alert |
| 02/13/2018 | CELG | Buy Now | Celgene | — | — | Geoff Meacham63% | — | Upgrade | Equal-Weight → Overweight | Get Alert |
| 02/01/2018 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.38 | -60.11% | Geoff Meacham63% | $180 → $200 | Maintains | Overweight | Get Alert |
| 01/31/2018 | PFE | Buy Now | Pfizer | $24.10 | 70.12% | Geoff Meacham63% | $38 → $41 | Maintains | Overweight | Get Alert |
| 11/08/2017 | ALNY | Buy Now | Alnylam Pharmaceuticals | $260.29 | -39.3% | Geoff Meacham63% | $127 → $158 | Maintains | Overweight | Get Alert |
| 11/02/2017 | NBIX | Buy Now | Neurocrine Biosciences | $108.61 | -21.74% | Geoff Meacham63% | $75 → $85 | Maintains | Overweight | Get Alert |
| 10/30/2017 | MRK | Buy Now | Merck & Co | $83.82 | — | Geoff Meacham63% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 10/27/2017 | CELG | Buy Now | Celgene | — | — | Geoff Meacham63% | $135 → $105 | Maintains | Equal-Weight | Get Alert |
| 10/23/2017 | DBVT | Buy Now | DBV Technologies | $8.68 | 245.62% | Geoff Meacham63% | $580 → $300 | Maintains | Overweight | Get Alert |
| 10/20/2017 | CELG | Buy Now | Celgene | — | — | Geoff Meacham63% | $140 → $135 | Maintains | Equal-Weight | Get Alert |
| 10/20/2017 | REGN | Buy Now | Regeneron Pharmaceuticals | $606.35 | — | Geoff Meacham63% | — | Downgrade | Equal-Weight → Underweight | Get Alert |
| 10/20/2017 | SGEN | Buy Now | Seagen | — | — | Geoff Meacham63% | — | Upgrade | Equal-Weight → Overweight | Get Alert |
| 10/18/2017 | JNJ | Buy Now | Johnson & Johnson | $155.95 | -5.1% | Geoff Meacham63% | $140 → $148 | Maintains | Equal-Weight | Get Alert |
| 10/16/2017 | SGEN | Buy Now | Seagen | — | — | Geoff Meacham63% | $55 → $60 | Maintains | Equal-Weight | Get Alert |
| 10/13/2017 | LLY | Buy Now | Eli Lilly | $816.25 | -87.99% | Geoff Meacham63% | $90 → $98 | Maintains | Overweight | Get Alert |
| 10/13/2017 | CELG | Buy Now | Celgene | — | — | Geoff Meacham63% | $135 → $140 | Maintains | Equal-Weight | Get Alert |
| 10/13/2017 | BMY | Buy Now | Bristol-Myers Squibb | $49.89 | 30.29% | Geoff Meacham63% | $58 → $65 | Maintains | Equal-Weight | Get Alert |
| 10/13/2017 | AMGN | Buy Now | Amgen | $277.38 | -31.5% | Geoff Meacham63% | $180 → $190 | Maintains | Equal-Weight | Get Alert |
| 10/13/2017 | ABBV | Buy Now | AbbVie | $195.53 | -53.97% | Geoff Meacham63% | $68 → $90 | Maintains | Equal-Weight | Get Alert |
| 10/11/2017 | GILD | Buy Now | Gilead Sciences | $103.45 | -13.01% | Geoff Meacham63% | → $90 | Reinstates | Overweight → Overweight | Get Alert |
| 09/29/2017 | PTCT | Buy Now | PTC Therapeutics | $49.60 | -69.76% | Geoff Meacham63% | $22 → $15 | Maintains | Equal-Weight | Get Alert |
| 09/22/2017 | VSAR | Buy Now | Versartis | — | — | Geoff Meacham63% | — | Downgrade | Overweight → Underweight | Get Alert |
| 09/21/2017 | ALNY | Buy Now | Alnylam Pharmaceuticals | $260.29 | -51.21% | Geoff Meacham63% | $105 → $127 | Maintains | Overweight | Get Alert |
| 09/20/2017 | XLRN | Buy Now | Acceleron Pharma | — | — | Geoff Meacham63% | $42 → $50 | Maintains | Overweight | Get Alert |
| 09/07/2017 | ALNY | Buy Now | Alnylam Pharmaceuticals | $260.29 | -59.66% | Geoff Meacham63% | $80 → $105 | Assumes | Equal-Weight → Overweight | Get Alert |
| 09/07/2017 | ZYME | Buy Now | Zymeworks | $13.14 | -39.12% | Geoff Meacham63% | → $8 | Assumes | Overweight → Underweight | Get Alert |
| 08/10/2017 | ALNY | Buy Now | Alnylam Pharmaceuticals | $260.29 | -73.11% | Geoff Meacham63% | $50 → $70 | Maintains | Equal-Weight | Get Alert |
| 08/02/2017 | INCY | Buy Now | Incyte | $61.80 | 166.97% | Geoff Meacham63% | $180 → $165 | Maintains | Overweight | Get Alert |
| 07/19/2017 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.38 | — | Geoff Meacham63% | — | Upgrade | Equal-Weight → Overweight | Get Alert |
| 05/30/2017 | BHVN | Buy Now | Biohaven | $23.26 | 28.98% | Geoff Meacham63% | → $30 | Initiates | → Overweight | Get Alert |
| 03/09/2017 | VSAR | Buy Now | Versartis | — | — | Geoff Meacham63% | → $168 | Initiates | → Overweight | Get Alert |
| 03/03/2017 | PTCT | Buy Now | PTC Therapeutics | $49.60 | -73.79% | Geoff Meacham63% | $20 → $13 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/29/2016 | UTHR | Buy Now | United Therapeutics | $295.94 | — | Geoff Meacham63% | — | Downgrade | Equal-Weight → Underweight | Get Alert |
| 11/29/2016 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.38 | — | Geoff Meacham63% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/29/2016 | SGEN | Buy Now | Seagen | — | — | Geoff Meacham63% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/29/2016 | JNJ | Buy Now | Johnson & Johnson | $155.95 | — | Geoff Meacham63% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/21/2016 | MYOV | Buy Now | Myovant Sciences | — | — | Geoff Meacham63% | → $18 | Initiates | → Overweight | Get Alert |
| 10/06/2016 | ALNY | Buy Now | Alnylam Pharmaceuticals | $260.29 | -80.79% | Geoff Meacham63% | $85 → $50 | Downgrade | Overweight → Equal-weight | Get Alert |
| 08/10/2016 | INCY | Buy Now | Incyte | $61.80 | 61.8% | Geoff Meacham63% | $85 → $100 | Maintains | Overweight | Get Alert |
| 08/05/2016 | IRWD | Buy Now | Ironwood Pharmaceuticals | $0.93 | 1189.77% | Geoff Meacham63% | $11 → $12 | Maintains | Equal-Weight | Get Alert |
| 08/04/2016 | PRTA | Buy Now | Prothena Corp | $9.03 | 675.19% | Geoff Meacham63% | $60 → $70 | Maintains | Overweight | Get Alert |
| 07/27/2016 | SGEN | Buy Now | Seagen | — | — | Geoff Meacham63% | $48 → $53 | Maintains | Overweight | Get Alert |
| 05/13/2016 | PRTA | Buy Now | Prothena Corp | $9.03 | 564.45% | Geoff Meacham63% | → $60 | Initiates | → Overweight | Get Alert |
| 02/26/2016 | UTHR | Buy Now | United Therapeutics | $295.94 | -51% | Geoff Meacham63% | $155 → $145 | Maintains | Equal-Weight | Get Alert |
| 02/19/2016 | IRWD | Buy Now | Ironwood Pharmaceuticals | $0.93 | 1082.29% | Geoff Meacham63% | $15 → $11 | Maintains | Equal-Weight | Get Alert |
| 02/12/2016 | INCY | Buy Now | Incyte | $61.80 | 37.53% | Geoff Meacham63% | $125 → $85 | Maintains | Overweight | Get Alert |
| 02/10/2016 | SGEN | Buy Now | Seagen | — | — | Geoff Meacham63% | $51 → $50 | Maintains | Overweight | Get Alert |
| 02/04/2016 | SGEN | Buy Now | Seagen | — | — | Geoff Meacham63% | → $51 | Initiates | → Overweight | Get Alert |
| 12/03/2015 | DBVT | Buy Now | DBV Technologies | $8.68 | 568.2% | Geoff Meacham63% | → $580 | Initiates | → Overweight | Get Alert |
| 08/13/2015 | INCY | Buy Now | Incyte | $61.80 | 102.25% | Geoff Meacham63% | → $125 | Initiates | → Overweight | Get Alert |
| 03/04/2015 | IRWD | Buy Now | Ironwood Pharmaceuticals | $0.93 | 1834.65% | Geoff Meacham63% | → $18 | Initiates | → Equal-Weight | Get Alert |
| 01/06/2015 | UTHR | Buy Now | United Therapeutics | $295.94 | -54.38% | Geoff Meacham63% | → $135 | Initiates | → Equal-weight | Get Alert |
| 01/06/2015 | CELG | Buy Now | Celgene | — | — | Geoff Meacham63% | → $120 | Initiates | → Equal-weight | Get Alert |
| 11/21/2014 | REGN | Buy Now | Regeneron Pharmaceuticals | $606.35 | -23.81% | Geoff Meacham63% | $418 → $462 | Maintains | Buy | Get Alert |
| 02/12/2014 | REGN | Buy Now | Regeneron Pharmaceuticals | $606.35 | -36.17% | Geoff Meacham63% | → $387 | Reinstates | → Buy | Get Alert |
| 12/26/2013 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Geoff Meacham63% | $129 → $162 | Maintains | Buy | Get Alert |
| 10/01/2013 | REGN | Buy Now | Regeneron Pharmaceuticals | $606.35 | -43.1% | Geoff Meacham63% | $310 → $345 | Maintains | Buy | Get Alert |
| 09/20/2013 | INCY | Buy Now | Incyte | $61.80 | -41.75% | Geoff Meacham63% | $22 → $36 | Maintains | Equal-Weight | Get Alert |
| 04/12/2013 | REGN | Buy Now | Regeneron Pharmaceuticals | $606.35 | -63.72% | Geoff Meacham63% | $200 → $220 | Maintains | Buy | Get Alert |
| 02/15/2013 | INCY | Buy Now | Incyte | $61.80 | -66.02% | Geoff Meacham63% | $19 → $21 | Maintains | Equal-Weight | Get Alert |
| 02/15/2013 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Geoff Meacham63% | $120 → $124 | Maintains | Buy | Get Alert |
| 10/10/2012 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Geoff Meacham63% | $118 → $130 | Maintains | Buy | Get Alert |
| 10/05/2012 | CELG | Buy Now | Celgene | — | — | Geoff Meacham63% | $37.5 → $43.5 | Maintains | Overweight | Get Alert |
| 09/24/2012 | REGN | Buy Now | Regeneron Pharmaceuticals | $606.35 | -71.63% | Geoff Meacham63% | $168 → $172 | Maintains | Buy | Get Alert |
| 08/28/2012 | REGN | Buy Now | Regeneron Pharmaceuticals | $606.35 | -72.29% | Geoff Meacham63% | $164 → $168 | Maintains | Buy | Get Alert |
| 08/28/2012 | REGN | Buy Now | Regeneron Pharmaceuticals | $606.35 | -72.29% | Geoff Meacham63% | $164 → $168 | Maintains | Buy | Get Alert |
| 08/03/2012 | INCY | Buy Now | Incyte | $61.80 | -66.02% | Geoff Meacham63% | $24 → $21 | Maintains | Equal-Weight | Get Alert |
| 05/29/2012 | REGN | Buy Now | Regeneron Pharmaceuticals | $606.35 | -73.94% | Geoff Meacham63% | $154 → $158 | Maintains | Buy | Get Alert |
| 05/08/2012 | REGN | Buy Now | Regeneron Pharmaceuticals | $606.35 | -74.6% | Geoff Meacham63% | $150 → $154 | Maintains | Buy | Get Alert |
| 04/23/2012 | REGN | Buy Now | Regeneron Pharmaceuticals | $606.35 | -75.92% | Geoff Meacham63% | $135 → $146 | Maintains | Buy | Get Alert |
| 03/27/2012 | REGN | Buy Now | Regeneron Pharmaceuticals | $606.35 | -77.74% | Geoff Meacham63% | $130 → $135 | Maintains | Buy | Get Alert |
| 03/26/2012 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Geoff Meacham63% | $92 → $99 | Maintains | Buy | Get Alert |
| 02/14/2012 | REGN | Buy Now | Regeneron Pharmaceuticals | $606.35 | -78.56% | Geoff Meacham63% | $105 → $130 | Maintains | Buy | Get Alert |
